Vonoprazan-based versus proton pump inhibitor-based therapy in Helicobacter pylori eradication: an updated systematic review and meta-analysis of randomised trials

Gut. 2024 Apr 5;73(5):872-874. doi: 10.1136/gutjnl-2023-329826.

Po-Yueh Chen¹, Feng-Pai Tsai², Mei-Jyh Chen^{3

4}, Hsin-Yi Yang⁵, Ming-Shiang Wu^{3

4}, Jyh-Ming Liou^{6

4

7}

¹ Internal Medicine, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi, Taiwan.
² Departments of Internal Medicine, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan.
³ Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
⁴ Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
⁵ Clinial Data Center, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi, Taiwan.
⁶ Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan jyhmingliou@gmail.com.
⁷ Department of Medicine, National Taiwan University Cancer Center, Taipei, Taiwan.

No abstract available

Keywords: HELICOBACTER PYLORI - TREATMENT; META-ANALYSIS.

Publication types

Proton Pump Inhibitors
1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine
Anti-Bacterial Agents
Amoxicillin
Pyrroles
Clarithromycin
Sulfonamides